Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Hashimoto

Showing results (241-250 of 248) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 248 results.
Cancer Science|January 4, 2026
Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in JapanShuhei Yamada, Miho Sato, Takahiro Osawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 28, 2026
Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional StudySayaka Shimizu, Takahiro Osawa, Miho Sato, et al.
Annals of Surgical Oncology|February 14, 2024
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical ProstatectomyMasaki Shiota, Dai Takamatsu, Yoshiyuki Matsui, et al.
International Journal of Clinical Oncology|July 8, 2024
Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvementTokiyoshi Tanegashima, Masaki Shiota, Takahiro Kimura, et al.
International Journal of Clinical Oncology|December 17, 2024
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, et al.
Cancer Science|April 29, 2022
Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancerMasaki Shiota, Dai Takamatsu, Takahiro Kimura, et al.
Cancer Science|June 19, 2021
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancerMasaki Shiota, Naoki Terada, Hiroshi Kitamura, et al.
Cancer Science|November 7, 2020
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patientsMasaki Shiota, Naoki Terada, Toshihiro Saito, et al.
Pageof 25

Showing results (241-250 of 248) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 248 results.
Cancer Science|January 4, 2026
Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in JapanShuhei Yamada, Miho Sato, Takahiro Osawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 28, 2026
Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional StudySayaka Shimizu, Takahiro Osawa, Miho Sato, et al.
Annals of Surgical Oncology|February 14, 2024
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical ProstatectomyMasaki Shiota, Dai Takamatsu, Yoshiyuki Matsui, et al.
International Journal of Clinical Oncology|July 8, 2024
Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvementTokiyoshi Tanegashima, Masaki Shiota, Takahiro Kimura, et al.
International Journal of Clinical Oncology|December 17, 2024
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, et al.
Cancer Science|April 29, 2022
Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancerMasaki Shiota, Dai Takamatsu, Takahiro Kimura, et al.
Cancer Science|June 19, 2021
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancerMasaki Shiota, Naoki Terada, Hiroshi Kitamura, et al.
Cancer Science|November 7, 2020
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patientsMasaki Shiota, Naoki Terada, Toshihiro Saito, et al.
Pageof 25